EFPIA Patients W.A.I.T. Indicator 2019 Survey
The yearly EFPIA Patients WAIT survey is now published
EFPIA Patients W.A.I.T. Indicator 2019 Survey
The yearly EFPIA Patients WAIT survey, developed with the support of IQVIA, has found that patients in neighboring countries can wait over 6 times as long for access to new medicines.
The study shows the average time to patient access to treatments across EU and European Economic Area (EEA) countries continues to be as long as 504 days, ranging from 127 days in Germany to over 823 days in Poland.
The study shows the average time to patient access to treatments across EU and European Economic Area (EEA) countries continues to be as long as 504 days, ranging from 127 days in Germany to over 823 days in Poland.